|
Yale SPORE in Skin Cancer
|
5P50CA121974-04
|
$2,233,298
|
$1,339,979
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$170,074
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia
|
5R37CA071692-13
|
$348,711
|
$87,178
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Wound Response Genes in Cancer Progression
|
5R01CA118750-03
|
$297,782
|
$297,782
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
Wnt-Dependent Neurite Outgrowth in Ewing Tumor Cells
|
ZIA BC 011224
|
$209,622
|
$62,887
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Wnt antagonist genes in kidney tumor progression and metastasis
|
5R01CA130860-02
|
$616,010
|
$616,010
|
DAHIYA, RAJVIR
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
|
Wine for Cancer-Associated Anorexia
|
5R01CA124614-03
|
$211,540
|
$211,540
|
JATOI, AMINAH
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Whole Body Hyperthermia and Anti-Tumor Immune Response
|
5R01CA071599-11
|
$287,503
|
$86,251
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
|
5R01CA095045-07
|
$273,560
|
$273,560
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Visualizing Immune Responses in vivo: a systems biology approach
|
1R21CA139168-01A1
|
$225,544
|
$56,386
|
Duda, Dan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Virus-host interactions in hepatocarcinogenesis
|
5P01CA123328-03
|
$1,060,761
|
$530,381
|
OU, J.-H. James
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
VEGF mRNA Expression Mechanisms in Hypoxia
|
5R01CA064436-13
|
$271,728
|
$271,728
|
CLAFFEY, KEVIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
VEGF Induced Signal Transduction
|
5R01CA086289-10
|
$301,024
|
$75,256
|
SIBINGA, NICHOLAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
2R37CA050286-21
|
$468,441
|
$468,441
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Vav3 Oncogene in Prostate Cancer
|
5R01CA119935-03
|
$266,760
|
$266,760
|
LU, SHAN
|
UNIVERSITY OF CINCINNATI
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-05
|
$114,400
|
$114,400
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Vanderbilt In Vivo Cellular and Molecular Imaging Center
|
5P50CA128323-02
|
$1,500,000
|
$150,000
|
GORE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Validation of genomic targets in melanoma
|
5R01CA114337-05
|
$294,871
|
$294,871
|
KASHANI-SABET, MOHAMMED
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-36S1
|
$59,955
|
$8,394
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-36
|
$4,736,061
|
$663,049
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-05
|
$2,180,817
|
$545,204
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
3P50CA093459-05S1
|
$1,079,303
|
$215,861
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-21
|
$2,091,787
|
$418,357
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using New Optical Techniques to Study Cell Signaling in 3D Matrices
|
5R21CA126635-02
|
$176,400
|
$176,400
|
KEELY, PATRICIA
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Uses of GEM models for Translational Cancer Research
|
1U01CA141508-01
|
$775,000
|
$775,000
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
|
Use of Quantitative RT-PCR for Staging Esophageal Cancer
|
5R01CA090665-09
|
$271,168
|
$271,168
|
LUKETICH, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$136,062
|
$95,243
|
Merlino, Glenn
|
CCR (NCI)
|
|
Use of Cystatin C to Combat TGF-Beta Tumorigenesis
|
5R01CA114039-05
|
$255,743
|
$255,743
|
SCHIEMANN, WILLIAM
|
UNIVERSITY OF COLORADO DENVER
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S1
|
$74,165
|
$16,316
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S2
|
$100,000
|
$22,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-34
|
$6,658,653
|
$1,464,904
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urokinase Receptor-initiated Cell-signaling
|
5R01CA094900-09
|
$268,139
|
$268,139
|
GONIAS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Urokinase Receptor Integrin Interactions in Lung Cancer
|
5R01CA125564-03
|
$293,550
|
$293,550
|
CHAPMAN, HAROLD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-07
|
$1,664,784
|
$566,027
|
FRONTERA, WALTER
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-07
|
$1,119,031
|
$380,471
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S2
|
$1,678,886
|
$335,777
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S3
|
$80,987
|
$16,197
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S4
|
$99,840
|
$19,968
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S2
|
$60,764
|
$6,076
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-05
|
$1,371,380
|
$137,138
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-22S1
|
$61,058
|
$12,212
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-22
|
$5,994,681
|
$1,198,936
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-02
|
$1,463,613
|
$146,361
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Unexpected Roles for the alpha2beta1 Integrin
|
5R01CA115984-05
|
$287,453
|
$71,863
|
ZUTTER, MARY
|
VANDERBILT UNIVERSITY
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
5K07CA130983-02
|
$126,582
|
$126,582
|
Riall, Taylor
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Understanding the Role of Autophagy in Cancer
|
5F32CA123777-04
|
$53,354
|
$53,354
|
DORSEY, FRANK
|
SCRIPPS RESEARCH INSTITUTE
|
|
Ultrastaging of Early Colon Cancer
|
5R01CA090848-06
|
$275,192
|
$275,192
|
BILCHIK, ANTON
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Ultrasound-guided gene delivery in pancreatic cancer
|
1R03CA140024-01
|
$70,542
|
$70,542
|
Claudio, Pier Paolo
|
MARSHALL UNIVERSITY
|
|
Ultrasound imaging and local drug delivery in tumors
|
2R01CA103828-06A1
|
$745,185
|
$186,296
|
FERRARA, KATHERINE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
UK SPORE in Gastrointestinal Cancer
|
1P20CA150343-01
|
$500,000
|
$200,000
|
EVERS, B
|
UNIVERSITY OF KENTUCKY
|
Total relevant funding to Metastasis for this search: $387,260,786
|